New Notices
- New Publication Announcement: Correction to Official Date of Posted IRA for Enoxaparin Sodium Monograph (posted 23-Nov-2022)
- New Notice of Intent to Revise: Carbomer 934, Carbomer 934P, Carbomer 941, and Carbomer 1342 (posted 18-Nov-2022)
- New Notice of Intent to Revise: Fosamprenavir Calcium (posted 18-Nov-2022)
- New Publication Announcement: Monographs Affected by Revision to <795> Pharmaceutical Compounding- Nonsterile Preparations (posted 01-Nov-2022)
- New Publication Announcement: Monographs Affected by Revision to <797> Pharmaceutical Compounding- Sterile Preparations (posted 01-Nov-2022)
- New Publication Announcement: Revised General Chapter <795> Published in USP-NF (posted 01-Nov-2022)
- New Publication Announcement: Revised General Chapter <797> Published in USP-NF (posted 01-Nov-2022)
- Updated Alcohol FAQs (posted 26-Oct-2022)
- New Notice of Intent to Revise: Fosfomycin Tromethamine (posted 05-Oct-2022)
- New Notice of Intent to Revise: Naloxone Hydrochloride (posted 30-Sep-2022)
- New Publication Announcement: Changes to USP's Description and Solubility Reference Table (posted 30-Sep-2022)
- New Publication Announcement: Monographs Affected by Revision to <126> Somatropin Bioidentity Tests (posted 30-Sep-2022)
- New General Announcement: Official Date Change for Enoxaparin Sodium Monograph Revision (posted 30-Sep-2022)
- New General Announcement: Pharmacopeial Forum 48(5) Stimuli Article: Selecting an Appropriate Volume for Subvisible Particles Per Container Calculation (posted 30-Sep-2022)
- New Notice of Intent to Revise: <621> Chromatography (posted 26-Aug-2022)
- New Notice of Intent to Revise: Tobramycin Sulfate (posted 26-Aug-2022)
- New General Announcement: Reporting Thresholds in Monographs- Proposed General Chapter <477> User-Determined Reporting Thresholds (posted 26-Aug-2022)
- New Notice of Intent to Revise: Ioxilan (posted 09-Aug-2022)
- Updated Notice of Intent to Revise: <711> Dissolution (posted 27-May-2022; updated 29-Jul-2022)
- New Notice of Intent to Revise: Rifabutin (posted 29-Jul-2022)
- Updated General Chapter Prospectus: <1568> Quality Considerations for Cannabis and Cannabis-derived Products for Clinical Research (updated 30-Jun-2022; input deadline 31-Jul-2022)